Cargando…
Unexpected Findings in a Child with Atypical Hemolytic Uremic Syndrome: An Example of How Genomics Is Changing the Clinical Diagnostic Paradigm
CBL is a tumor suppressor gene on chromosome 11 encoding a multivalent adaptor protein with E3 ubiquitin ligase activity. Germline CBL mutations are dominant. Pathogenic de novo mutations result in a phenotype that overlaps Noonan syndrome (1). Some patients with CBL mutations go on to develop juven...
Autores principales: | Seaby, Eleanor G., Gilbert, Rodney D., Andreoletti, Gaia, Pengelly, Reuben J., Mercer, Catherine, Hunt, David, Ennis, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438966/ https://www.ncbi.nlm.nih.gov/pubmed/28589114 http://dx.doi.org/10.3389/fped.2017.00113 |
Ejemplares similares
-
Progressive myoclonic epilepsy with Fanconi syndrome
por: Seaby, Eleanor G, et al.
Publicado: (2016) -
Case Report: Denys–Drash Syndrome With WT1 Causative Variant Presenting as Atypical Hemolytic Uremic Syndrome
por: Cheng, Cheng, et al.
Publicado: (2020) -
Successful Discontinuation of Eculizumab in a Pediatric Patient With Atypical Hemolytic Uremic Syndrome and Underlying Systematic Lupus Erythematosus
por: Alhamoud, Issa, et al.
Publicado: (2022) -
Clinical features and management of atypical hemolytic uremic syndrome patient with DGKE gene variants: a case report
por: Dai, Xiaomei, et al.
Publicado: (2023) -
Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)